Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Dr. Reddy's Laboratories Limited의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Dr. Reddy's Laboratories Limited 주요 수익원은 Global Generics이며, 최신 수익 발표에서 수익은 289,552,000,000입니다. 지역별로는 United States이 Dr. Reddy's Laboratories Limited의 주요 시장이며, 수익은 149,351,000,000입니다.
Dr. Reddy's Laboratories Limited은 수익성이 있나요?
no, 최신 재무제표에 따르면 Dr. Reddy's Laboratories Limited의 순손실은 $0입니다.